Plain-English translation of NCT06214767 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study for people who have been diagnosed with cerebral cavernous malformations (CCMs)—abnormal blood vessel clusters in the brain. Researchers want to use artificial intelligence and advanced imaging analysis to predict which patients are at higher risk for complications like bleeding or seizures. By understanding these risks better, doctors hope to create a personalized tool to help decide the best treatment plan for each patient.
Many people with brain cavernous malformations are uncertain whether they need surgery or if watching and waiting is safe. This study exists to help doctors predict which patients are most likely to have problems, so treatment decisions can be tailored to each person's actual risk rather than using a one-size-fits-all approach.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital regularly over three years for brain imaging scans (MRI) to monitor your cavernous malformation. You'll also share your medical history, past test results, and allow researchers to use your imaging data for artificial intelligence analysis. If you end up needing surgery during the study, researchers may also ask to study the tissue removed during that procedure. The study focuses on observation and data collection rather than giving you a new treatment.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China